Aspiriant LLC’s Dover DOV Stock Holding History

Aspiriant LLC’s Portfolio DOV Stock Details DOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,136	Closed	-$201K	–	300
2024 Q1	$201K	Buy	+1,136	New	+$183K	0.01%	310

Other funds holding DOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Aspiriant LLC's DOV Position: Q2 2024 in Review

Aspiriant LLC sold out of Dover (DOV) in Q2 2024, closing a stake of 1,136 shares — an estimated $201K sold.

Aspiriant LLC first reported a position in DOV in Q1 2024 and held it in 1 quarter. The position peaked at $201K in Q1 2024. 953 funds tracked by Wall St. Rank hold DOV as of Q2 2024.

Aspiriant LLC reported no remaining Dover position as of Q2 2024 after selling out during the quarter.
Aspiriant LLC sold 1,136 Dover shares in Q2 2024, an estimated $201K.
Aspiriant LLC first reported a position in Dover in Q1 2024 and held it in 1 quarter.
Aspiriant LLC's Dover position peaked at $201K in Q1 2024.
953 funds tracked by Wall St. Rank held Dover as of Q2 2024.

Based on Aspiriant LLC's 13F filing for Q2 2024, filed 15 Jul 2024.